Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. The company is headquartered in Rahway, New Jersey and currently employs 75,000 full-time employees. Its Pharmaceutical segment includes human health pharmaceutical and vaccine products. The firm sells its human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers. The company sells these human health vaccines primarily to physicians, wholesalers, distributors and government entities. Its Animal Health segment discovers, develops, manufactures and markets a range of veterinary pharmaceutical and vaccine products, as well as health management solutions and services, for the prevention, treatment and control of disease in all livestock and companion animal species. Its products include KEYTRUDA (pembrolizumab) injection, for intravenous use; WELIREG (belzutifan) tablets, for oral use; Ohtuvayre (ensifentrine) and others.
Mr. Robert Davis es el Chairman of the Board de Merck & Co Inc, se unió a la empresa desde 2014.
¿Qué tal es el rendimiento del precio de la acción MRK?
El precio actual de MRK es de $115.34, ha disminuido un 0.28% en el último día de negociación.
¿Cuáles son los temas de negocio principales o las industrias de Merck & Co Inc?
Merck & Co Inc pertenece a la industria Pharmaceuticals y el sector es Health Care
¿Cuál es la capitalización bursátil de Merck & Co Inc?
La capitalización bursátil actual de Merck & Co Inc es $285.1B
¿Es Merck & Co Inc una compra, una venta o una posición de mantener?
Según los analistas de Wall Street, 30 analistas han realizado calificaciones de análisis para Merck & Co Inc, incluyendo 7 fuerte compra, 12 compra, 14 mantener, 0 venta, y 7 fuerte venta